Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16538009 | 0.69 | MAOA (0.43) | — | |
| SCHEMBL8791995 | 0.67 | CES1 (0.54) | — | |
| SCHEMBL3922182 | 0.66 | MAOA (0.43) | — | |
| SCHEMBL29699894 | 0.65 | NTSR1 (0.33) | — | |
| SCHEMBL7753388 | 0.65 | MAPT (0.42) | — | |
| SCHEMBL1399934 | 0.64 | CA12 (0.41) | AHR | |
| SCHEMBL29457692 | 0.64 | ALDH1A1 (0.49) | — | |
| SCHEMBL261907 | 0.64 | CES1 (0.39) | — | |
| SCHEMBL28346161 | 0.62 | — | — | |
| SCHEMBL29385734 | 0.60 | CES1 (0.45) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10869939-B2 | Delivery system in micellar form having modular spectral response based on enzyme-responsive amphiphilic PEG-dendron hybrid polymers | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2020-12-22 | — | — | US | claimed |
| US-20190162730-A1 | METHOD, COMPOSITION AND SENSOR FOR ANALYTE DETECTION | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2019-05-30 | — | — | US | claimed |
| EP-3469096-A1 | METHOD, COMPOSITION AND SENSOR FOR ANALYTE DETECTION | Cambridge Display Technology Limited (GB) | 2019-04-17 | — | — | EP | claimed |
| WO-2017216525-A1 | METHOD, COMPOSITION AND SENSOR FOR ANALYTE DETECTION | CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) | 2017-12-21 | — | — | WO | claimed |
| US-20170035916-A1 | DELIVERY SYSTEM IN MICELLAR FORM HAVING MODULAR SPECTRAL RESPONSE BASED ON ENZYME-RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRID POLYMERS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2017-02-09 | — | — | US | claimed |
| US-9310315-B2 | Methods for detecting defects in inorganic-coated polymer surfaces | Life Technologies Corporation (US) | 2016-04-12 | — | — | US | claimed |
| CN-103364381-B | For detecting the method for the defect in inorganic-coated polymer surfaces | LIFE TECHNOLOGIES, INC. (US) | 2016-04-06 | — | — | CN | claimed |
| EP-2554975-A1 | Method and substrate for detecting defects in inorganic-coated polymer surfaces | Life Technologies Corporation (US) | 2013-02-06 | — | — | EP | claimed |
| US-8304242-B2 | Methods for detecting defects in inorganic-coated polymer surfaces | Life Technologies Corporation (US) | 2012-11-06 | — | — | US | claimed |
| US-20260048008-A1 | ORGANOGELS FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | OCULAR THERAPEUTIX INC (US) | 2026-02-19 | — | — | US | disclosed |
| EP-4695324-A1 | BIO-ORTHOGONAL HYDROGELS FOR SUSTAINED RELEASE DRUG DELIVERY | Ocular Therapeutix, Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4683964-A2 | POLY(ETHYLENE GLYCOL) BASED DENDRIMER-LIKE HYPERBRANCHED MACROMOLECULES, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2026-01-28 | — | — | EP | disclosed |
| EP-4665307-A1 | BIODEGRADABLE MICROPARTICLES FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2025-12-24 | — | — | EP | disclosed |
| EP-4568658-A1 | ORGANOGELS FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | Ocular Therapeutix, Inc. (US) | 2025-06-18 | — | — | EP | disclosed |
| US-20130020507-A1 | Methods for Detecting Defects in Inorganic-Coated Polymer Surfaces | Life Technologies Corporation (US) | 2013-01-24 | — | — | US | disclosed |
| US-8304242-B2 | Methods for detecting defects in inorganic-coated polymer surfaces | Life Technologies Corporation (US) | 2012-11-06 | — | — | US | disclosed |
| US-20100291685-A1 | METHODS FOR DETECTING DEFECTS IN INORGANIC-COATED POLYMER SURFACES | Life Technologies Corporation (US) | 2010-11-18 | — | — | US | disclosed |
| EP-2223087-A2 | METHODS FOR DETECTING DEFECTS IN INORGANIC-COATED POLYMER SURFACES | Life Technologies Corporation (US) | 2010-09-01 | — | — | EP | disclosed |
| WO-2009079571-A2 | METHODS FOR DETECTING DEFECTS IN INORGANIC-COATED POLYMER SURFACES | Life Technologies Corporation (US) | 2009-06-25 | — | — | WO | disclosed |
| US-5786219-A | POLYMERIC MICROSPHERE DISPLAYING DISTINCT FLUORESCENT RING CONCENTRIC WITH AND WITHIN SAID SPHERE; LABELS, CALIBRATING MICROSCOPES | MOLECULAR PROBES, INC. (US) | 1998-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048008-A1 | ORGANOGELS FOR SUSTAINED DRUG DELIVERY, METHODS OF PREPARATION AND USE THEREOF | KIT, IL33, LY96 | AHR 1038/4885 |
| US-20170035916-A1 | DELIVERY SYSTEM IN MICELLAR FORM HAVING MODULAR SPECTRAL RESPONSE BASED ON ENZYME-RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRID POLYMERS | JMJD7, HM13, APEH | AHR 2362/4885 |
| US-10869939-B2 | Delivery system in micellar form having modular spectral response based on enzyme-responsive amphiphilic PEG-dendron hybrid polymers | JMJD7, HM13, APEH | AHR 2362/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.